However, the IL-6 −174G/C polymorphism may affect the severity of positive symptoms and cognitive impairments observed in schizophrenia and might be the consequence of IL-6 serum levels, thereby, highlighting that schizophrenia is a progressive disorder with low-grade inflammation, essential for its pathophysiology that is then followed by cognitive decline. This evidence concerns the gene IL6 and schizophrenia.